BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Amgen 

Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

Genesis Research and Development Corporation 

Phylos, Inc.  In 2000, Phylos entered into collaboration with Amgen to apply Phylos' PROfusion™ technology to rapidly identify high-affinity binding agents to potential therapeutic targets supplied by Amgen. Amgen will use the sequences and structural information gained through this collaboration for its internal drug discovery programs.

UCB, Inc.  Contract manufacturing of Abarelix peptide active ingredient

EPIX Pharmaceuticals, Inc. 

Dyax Corp.  Antibody phage display





 Company News
FDA Grants Amgen (AMGN) Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 8/27/2014 8:03:55 AM
Amgen (AMGN), Bristol-Myers Squibb Company (BMY) On The Prowl For Space In Crowded Cambridge, Massachusetts 8/19/2014 10:02:02 AM
Good News For Amgen (AMGN) As Parathyroid Drug AMG 416 Succeeds In Phase 3 Study 8/18/2014 3:58:43 PM
Amgen (AMGN) Recalls Nine Packaged Lots Of Aranesp 8/13/2014 4:16:18 PM
Amgen (AMGN) Drops After Hours On Failed Phase 3 Multiple Myeloma Trial 8/13/2014 4:14:02 PM
Trial A Success, Amgen (AMGN) CEO Doesn't Have To Quit 8/5/2014 6:00:19 AM
Blow To Amgen (AMGN)'s Profits As Express Scripts Inc. Drops Drugs From List Of Preferred Drugs 8/4/2014 6:08:21 AM
Amgen (AMGN) Drug Kyprolis Helped Patients Live 8.7 Months Longer In Late-Stage Trial 8/4/2014 5:53:58 AM
Amid Cuts, Amgen (AMGN) To Add Jobs In Cambridge, Massachusetts 7/30/2014 11:28:42 AM
Amgen (AMGN)'s Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (Eps) Increased 25 Percent To $2.37 7/30/2014 9:05:48 AM
12345678910...